إسرائيل - العربية - Ministry of Health

j-c health care ltd - loperamide hydrochloride 2 mg - capsules - antipropulsives - control and symptomatic relief of acute diarrhea.

إسرائيل - العربية - Ministry of Health

dexcel ltd - metformin hydrochloride 850 mg - caplets - metformin - treatment of non-insulin diabetes mellitus not responding to dietary modification.

إسرائيل - العربية - Ministry of Health

abic ltd. - propranolol hydrochloride 160 mg - capsules - propranolol - management of angina pectoris. control of essential and renal hypertension and essential tremor.as an adjunct in the management of tachycardias and arrhythmias due to thyrotoxicosis and thyrotoxic crises. migraine prophylaxis.

إسرائيل - العربية - Ministry of Health

sanofi - aventis israel ltd - alfuzosin hydrochloride 10 mg - tablets prolonged release - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy particularly if surgery has to be delayed for some reason. adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.

إسرائيل - العربية - Ministry of Health

teva pharmaceutical indust.ltd - terazosin as hydrochloride dihydrate 5 mg - tablets - terazosin - for symptomatic treatment of urinary obstructon caused by benign prostatic hyperplasia (bph). for mild to moderate hypertension.

إسرائيل - العربية - Ministry of Health

amgen europe b.v. - cinacalcet hydrochloride 30 mg - film coated tablets - cinacalcet - treatment of secondary hyperparathyrodism (hpt) in patients with end-dtage renal disease (esrd) on maintenance dialysis therapy. mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with parathyroid carcinoma.

إسرائيل - العربية - Ministry of Health

amgen europe b.v. - cinacalcet hydrochloride 60 mg - film coated tablets - cinacalcet - treatment of secondary hyperparathyrodism (hpt) in patients with end-dtage renal disease (esrd) on maintenance dialysis therapy. mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with parathyroid carcinoma.

إسرائيل - العربية - Ministry of Health

amgen europe b.v. - cinacalcet hydrochloride 90 mg - film coated tablets - cinacalcet - treatment of secondary hyperparathyrodism (hpt) in patients with end-dtage renal disease (esrd) on maintenance dialysis therapy. mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols as appropriate. reduction of hypercalcaemia in patients with parathyroid carcinoma.